Press release
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics Market
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here
News-ID: 3825669 • Views: …
More Releases from The Insight Partners
Cutaneous Fibrosis Treatment Market Poised for Steady Growth Through 2034
The Cutaneous Fibrosis Treatment Market is expected to record consistent growth from 2026 to 2034. The market outlook is positive, driven by evolving industry requirements, technological advancements, and increasing adoption of patient-centric treatment approaches. The market addresses conditions such as keloid, scleroderma, radiation-induced cutaneous fibrosis, and GvHD-associated cutaneous fibrosis, with therapies delivered via oral, injectable, and topical routes in hospitals and clinics.
Get Sample PDF Brochure:
https://www.theinsightpartners.com/sample/TIPRE00016848/?utm_source=OpenPR&utm_medium=10914
Purpose of the Report
The report by…
Biodefense Market Witnesses Robust Expansion Amid Rising Global Security Priorit …
Governments worldwide continue to bolster defenses against biological threats through strategic investments and innovative technologies. This press release explores key drivers, emerging trends, and promising opportunities in the biodefense sector, drawing from established market analysis.
The biodefense market size in 2021 stood at US$ 12.37 billion and is projected to reach US$ 21.62 billion by 2031. The market is expected to register a CAGR of 6.1% in 2023-2031. Big data and…
HVAC Air Duct Market Analysis Highlights Key Trends, Demand Drivers, and Forecas …
The HVAC Air Duct Market continues to expand steadily, fueled by ongoing urbanization and a strong push for better indoor environments in buildings worldwide. Recent insights highlight how construction booms and regulatory shifts are shaping demand for efficient duct solutions across commercial, residential, and industrial spaces.
The HVAC air duct market size is expected to reach US$22.27 billion by 2034 from US$15.51 billion in 2025. The market is anticipated to register…
Deck Design Software Market Analysis Highlights Key Trends, Growth Drivers, and …
The Deck Design Software Market continues to expand as more homeowners and professionals turn to digital tools for creating appealing outdoor spaces. This growth reflects broader shifts toward personalized living areas and advanced technology in design.
The deck design software market size is projected to reach US$ 794.63 million by 2031 from US$ 262.67 million in 2023. The market is expected to register a CAGR of 14.8 % in 2023-2031.
Download PDF…
More Releases for Pharmacogenomics
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'
Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period…
